TickerGuard
Buy Day today: Good (67) Broad market participation · no major macro event

Cytokinetics Inc (CYTK)

Healthcare Biotechnology
76.50 $
-0.9% vs. previous close
Closing price · As of: 3. Aug 2026

Cytokinetics Inc (CYTK) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 1,425 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Balance Sheet CYTK
Tick rows to compare them in a chart (up to 4) 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
133 115 170 295 211 290 534 841 1,015 824 1,402 1,425
131 113 159 274 208 234 474 536 795 628 1,108 917
20 65 67 125 42 36 83 113 66 113 95 123
83 111 156 269 199 225 464 472 783 615 1,076 882
47 0.0 0.0 1.1 6.8 5.2 4.4 52 0.1 1.3 17 18
0.0 0.0 0.0 0.0 -6.8 -4.4 -52 -0.1 -12
1.6 1.8 3.6 3.6 3.2 4.5 13 73 80
0.0 0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0 0.0
41 47 76 185 185 301 420 597 1,123 1,211 1,537 2,084
24 32 33 32 22 26 31 72 85 103 180 202
1.4 2.2 2.5 5.3 2.6 4.6 2.8 15 14 28 30 60
1.4 2.2 4.2 5.3 3.8 8.2 8.1 21 26 22 20 22
0.0 15 27 32 40 45 46 47 64 607 646 1,116
92 69 94 110 26 -11 113 244 -108 -386 -135 -660
-497 -535 -518 -646 -743 -865 -992 -1,208 -1,586 -2,112 -2,702 -3,487
36 39 43 49 54 58 65 77 90 97 112 120

Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?